Tyck till om SwePub Sök
här!
Sökning: onr:"swepub:oai:DiVA.org:umu-180715" >
Tumour inflammation...
Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer
-
- Mints, Michael (författare)
- Karolinska Institutet,Umeå universitet,Urologi och andrologi,Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
-
- Landin, David (författare)
- Karolinska Institutet
-
- Näsman, Anders (författare)
- Karolinska Institutet
-
visa fler...
-
Mirzaie, Leila (författare)
-
Ursu, Ramona Gabriela (författare)
-
Zupancic, Mark (författare)
-
- Marklund, Linda (författare)
- Karolinska Institutet
-
- Dalianis, Tina (författare)
- Karolinska Institutet
-
- Munck-Wikland, Eva (författare)
- Karolinska Institutet
-
- Ramqvist, Torbjörn (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2021-01-19
- 2021
- Engelska.
-
Ingår i: Scientific Reports. - : Nature Publishing Group. - 2045-2322. ; 11:1
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://www.nature.c...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Hypopharyngeal squamous cell carcinoma (HPSCC) has a very poor prognosis. Local surgery may increase survival, but is often avoided due to significant post-op co-morbidities. Since prognostic markers are lacking, the aim was to find predictive biomarkers that identify patients whose response to oncological treatment is poor and who may benefit from primary surgery to increase survival. Pretreatment biopsies from 23 HPSCC patients, 3 human papillomavirus (HPV) positive and 20 HPV-negative, were analyzed for expression of 750 mRNAs using the Nanostring nCounter IO360 panel in relation to 3-year survival. Validation was performed through immunohistochemistry (IHC) for HLA class I and S100A12 in 74 HPV-negative HPSCC samples. Clustering identified a subset of HPV-negative HPSCC with favorable prognosis and a gene expression signature overexpressing calgranulins and immune genes, distinct from that of HPV-positive HPSCC. Enrichment analysis showed immune signaling, including the tumor inflammation signature, to be enriched in surviving patients. IHC validation confirmed high S100A12 and HLA class I expression to correlate with survival in HPV-negative HPSCC. This shows that immune activity is strongly related to survival in HPV-negative HPSCC. Enrichment of the tumor inflammation signature indicates a potential benefit of immunotherapy. Low expression of both HLA class I and S100A12 could be used to select patients for local surgery.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Mints, Michael
-
Landin, David
-
Näsman, Anders
-
Mirzaie, Leila
-
Ursu, Ramona Gab ...
-
Zupancic, Mark
-
visa fler...
-
Marklund, Linda
-
Dalianis, Tina
-
Munck-Wikland, E ...
-
Ramqvist, Torbjö ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
Scientific Repor ...
- Av lärosätet
-
Umeå universitet
-
Karolinska Institutet